Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1473, 2005-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Sleep therapy, hypnosedative use in cancer associated with QOL
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 470, 2005-01 ,pp. :
Hypnosedative use "substantially" elevates risk of death, cancer
Reactions Weekly, Vol. 1, Iss. 1392, 2012-01 ,pp. :
Sertraline plus sleep deprivation therapy boosts QOL in MDD
Inpharma, Vol. 1, Iss. 1510, 2005-01 ,pp. :
Sertraline plus sleep deprivation therapy boosts QOL in MDD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 489, 2005-01 ,pp. :
Concomitant hypnosedative, donepezil use common in elderly with AD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 416, 2003-01 ,pp. :